Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Manczak

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Human Molecular Genetics|October 18, 2017
Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's diseaseRamesh Kandimalla, Maria Manczak, Xiangling Yin, et al.
Human Molecular Genetics|September 29, 2016
Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's diseaseMaria Manczak, Ramesh Kandimalla, David Fry, et al.
Human Molecular Genetics|December 17, 2021
A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer diseaseRamesh Kandimalla, Maria Manczak, Jangampalli Adi Pradeepkiran, et al.
Human Molecular Genetics|August 30, 2011
Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's diseaseMarcus J Calkins, Maria Manczak, Peizhong Mao, et al.
Journal of Neurochemistry|January 22, 2005
Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in agingMaria Manczak, Youngsin Jung, Byung S Park, et al.
Frontiers in Aging Neuroscience|June 26, 2026
Transsynaptic complex dysfunction in the hippocampus of Alzheimer's disease patientsAshly Hindle, Yong Chen, Xiangling Yin, et al.
Human Molecular Genetics|February 8, 2017
Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's diseaseRamesh Kandimalla, Maria Manczak, David Fry, et al.
Neuroscience Letters|July 12, 2011
A transgenic mouse model for Alzheimer's disease has impaired synaptic gain but normal synaptic dynamicsUlises M Ricoy, Peizhong Mao, Maria Manczak, et al.
Human Molecular Genetics|October 10, 2019
Protective effects of BACE1 inhibitory ligand molecules against amyloid beta-induced synaptic and mitochondrial toxicities in Alzheimer's diseaseJangampalli Adi Pradeepkiran, Arubala P Reddy, Xiangling Yin, et al.
Human Molecular Genetics|July 21, 2009
Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's diseaseMaria Manczak, Peizhong Mao, Kazuhiro Nakamura, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Human Molecular Genetics|October 18, 2017
Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's diseaseRamesh Kandimalla, Maria Manczak, Xiangling Yin, et al.
Human Molecular Genetics|September 29, 2016
Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's diseaseMaria Manczak, Ramesh Kandimalla, David Fry, et al.
Human Molecular Genetics|December 17, 2021
A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer diseaseRamesh Kandimalla, Maria Manczak, Jangampalli Adi Pradeepkiran, et al.
Human Molecular Genetics|August 30, 2011
Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's diseaseMarcus J Calkins, Maria Manczak, Peizhong Mao, et al.
Journal of Neurochemistry|January 22, 2005
Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in agingMaria Manczak, Youngsin Jung, Byung S Park, et al.
Frontiers in Aging Neuroscience|June 26, 2026
Transsynaptic complex dysfunction in the hippocampus of Alzheimer's disease patientsAshly Hindle, Yong Chen, Xiangling Yin, et al.
Human Molecular Genetics|February 8, 2017
Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's diseaseRamesh Kandimalla, Maria Manczak, David Fry, et al.
Neuroscience Letters|July 12, 2011
A transgenic mouse model for Alzheimer's disease has impaired synaptic gain but normal synaptic dynamicsUlises M Ricoy, Peizhong Mao, Maria Manczak, et al.
Human Molecular Genetics|October 10, 2019
Protective effects of BACE1 inhibitory ligand molecules against amyloid beta-induced synaptic and mitochondrial toxicities in Alzheimer's diseaseJangampalli Adi Pradeepkiran, Arubala P Reddy, Xiangling Yin, et al.
Human Molecular Genetics|July 21, 2009
Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's diseaseMaria Manczak, Peizhong Mao, Kazuhiro Nakamura, et al.
Pageof 6